Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

ClinicalTrials.gov ID: NCT04795141

Public ClinicalTrials.gov record NCT04795141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

Study identification

NCT ID
NCT04795141
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Inmagene LLC
Industry
Enrollment
25 participants

Conditions and interventions

Interventions

  • ABY-035 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 23, 2021
Primary completion
Jul 10, 2022
Completion
Aug 29, 2022
Last update posted
Jul 11, 2023

2021 – 2022

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research, PLLC Glendale Arizona 85306
Hope Clinical Research Canoga Park California 91303
Newport Huntington Medical Group Huntington Beach California 92648
Desert Medical Advances Palm Desert California 92260
Arthritis and Rheumatic Disease Specialties Aventura Florida 33180
Drucker Sarasota Arthritis Research Center Sarasota Florida 34293
Greater Chicago Specialty Physicians/ Clinical Investigation Specialists, Inc. Schaumburg Illinois 60195
Clinic of Robert Hozman, MD / Clinical Investigation Specialists, Skokie Illinois 60076
Klein & Associates, M.D., P.A. Hagerstown Maryland 21740
The Center for Rheumatology and Bone Research Wheaton Maryland 20902
M3 Emerging Medical Research, LLC Durham North Carolina 27704
Clinical Research Source, Inc. Perrysburg Ohio 43551
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
HRMD Research Dallas Texas 75240
Seattle Rheumatology Associates Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04795141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04795141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →